Anti-alpha 1 Adrenergic Receptor antibody (ab166925)

Overview

  • Product name
    Anti-alpha 1 Adrenergic Receptor antibody
    See all alpha 1 Adrenergic Receptor primary antibodies
  • Description
    Goat polyclonal to alpha 1 Adrenergic Receptor
  • Tested applications
    Suitable for: WBmore details
  • Species reactivity
    Reacts with: Mouse, Rat, Human, Pig
    Predicted to work with: Rabbit, Guinea pig, Cow, Dog, Cynomolgus monkey, Chinese hamster
  • Immunogen

    Synthetic peptide corresponding to Human alpha 1 Adrenergic Receptor aa 266-278 (Cysteine residue).
    Sequence:

    SSTKAKGHNPRSS


    Database link: NP_000670.1

  • Positive control
    • WB: Human, mouse, pig and rat heart lysates.

Properties

Applications

Our Abpromise guarantee covers the use of ab166925 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB Use a concentration of 0.1 - 0.3 µg/ml. Predicted molecular weight: 57 kDa.

Target

Images

  • All lanes : Anti-alpha 1 Adrenergic Receptor antibody (ab166925) at 0.1 µg/ml

    Lane 1 : Human heart lysate (in RIPA buffer)
    Lane 2 : Mouse heart lysate (in RIPA buffer)
    Lane 3 : Rat heart lysate (in RIPA buffer)

    Lysates/proteins at 35 µg per lane.

    Developed using the ECL technique

    Predicted band size : 57 kDa

    Primary incubation was 1 hour.

  • Anti-alpha 1 Adrenergic Receptor antibody (ab166925) at 0.1 µg/ml + Pig heart lysate (in RIPA buffer) at 35 µg
    Developed using the ECL technique

    Predicted band size : 57 kDa

    Primary incubation was 1 hour.

References

ab166925 has not yet been referenced specifically in any publications.

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab166925.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up